Correlation Between Visa and 10X Genomics
Can any of the company-specific risk be diversified away by investing in both Visa and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and 10X Genomics, you can compare the effects of market volatilities on Visa and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and 10X Genomics.
Diversification Opportunities for Visa and 10X Genomics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Visa and 10X is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Visa i.e., Visa and 10X Genomics go up and down completely randomly.
Pair Corralation between Visa and 10X Genomics
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.31 times more return on investment than 10X Genomics. However, Visa Class A is 3.19 times less risky than 10X Genomics. It trades about 0.33 of its potential returns per unit of risk. 10X Genomics is currently generating about -0.06 per unit of risk. If you would invest 28,960 in Visa Class A on August 31, 2024 and sell it today you would earn a total of 2,510 from holding Visa Class A or generate 8.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Visa Class A vs. 10X Genomics
Performance |
Timeline |
Visa Class A |
10X Genomics |
Visa and 10X Genomics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and 10X Genomics
The main advantage of trading using opposite Visa and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
10X Genomics vs. Twist Bioscience Corp | 10X Genomics vs. Fate Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Veracyte |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |